UFLEX Limited has informed the Exchange regarding a press release dated May 19, 2025, titled "Earnings Release for the quarter and financial year ended 31st March, 2025".
UFLEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
UFLEX reported FY25 consolidated revenue of Rs. 15,184 crore, up 12.4% YoY, with normalized EBITDA of Rs. 1,902 crore (+18.1% YoY) and EBITDA margin expanding 60 bps to 12.5%. Normalized PAT jumped 77.5% to Rs. 320 crore. Q4 FY25 revenue rose 10.8% YoY to Rs. 3,874 crore, with normalized EBITDA up 5.1% YoY at Rs. 478 crore (12.3% margin). Sales volumes grew 8% YoY to 6.47 lakh MT, led by packaging films (77.7% of mix). However, net debt rose to Rs. 6,843 crore from Rs. 5,569 crore YoY, with net debt-to-EBITDA worsening to 3.6x. Management is investing heavily in a new aseptic plant in Egypt (USD 126M), WPP bags plant in Mexico (USD 50M), and recycling capacity, which they expect to drive margin and ROCE expansion from FY27.
Strong FY25 results show margin recovery and volume growth, supportive of the stock. But rising debt and leverage are concerns — shareholders should watch for capex-led cash flow improvement once the Egypt and Mexico plants commission in FY26.